Constantina Chrysochou

Author

Salford Royal NHS Foundation Trust ORCID

Also Known As

C Chrysochou, C. Chrysochou, CONSTANTINA CHRYSOCHOU, Chrysochou, C., Chrysochou, Constantina, Constantina Chrysochou, Coralie Bingham, David Adlam, Kaivan Khavandi, Martin Christian

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Salford Royal NHS Foundation Trust Salford Royal Hospital University of Manchester Manchester Academic Health Science Centre University of Salford

About

Constantina Chrysochou is an author at Salford Royal NHS Foundation Trust specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	521
2	Emergency Medicine	2	2	48
3	Engineering	1	1	40
4	Public Health	1	1	191
5	Epidemiology	1	1	191

Constantina Chrysochou

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Serum Phosphate and Mortality in Patients with Chronic Kidney Disease Helen Eddington, Richard Hoefield, Smeeta Sinha, Clinical Journal of the American Society of Nephrology	2010	236
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, The Lancet	2023	224
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, The Lancet GlomerulonephritisActive-controlled Clinical TrialRenal FunctionKidney FailureChronic Kidney Disease	2023	203
High-Risk Clinical Presentations in Atherosclerotic Renovascular Disease: Prognosis and Response to Renal Artery Revascularization James Ritchie, Darren Green, Constantina Chrysochou, American Journal of Kidney Diseases High-risk Clinical PresentationsVascular DiseaseUrologyCardiovascular DiseaseVascular Surgery	2013	191
Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease Constantina Chrysochou, Robert N. Foley, John F. Young, Nephrology Dialysis Transplantation	2011	120
The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease Philip A. Kalra, Constantina Chrysochou, Darren Green, Catheterization and Cardiovascular Interventions	2009	90
BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease Constantina Chrysochou, Iosif Mendichovszky, David L. Buckley, Nephrology Dialysis Transplantation	2011	74
Low Risk for Nephrogenic Systemic Fibrosis in Nondialysis Patients Who Have Chronic Kidney Disease and Are Investigated with Gadolinium-Enhanced Magnetic Resonance Imaging Constantina Chrysochou, Albert Power, A.E. Shurrab, Clinical Journal of the American Society of Nephrology	2010	72
Effects of renal volume and single-kidney glomerular filtration rate on renal functional outcome in atherosclerotic renal artery stenosis Chui Ming Gemmy Cheung, Constantina Chrysochou, A.E. Shurrab, Nephrology Dialysis Transplantation	2009	43
The effect of revascularization in patients with anatomically significant atherosclerotic renovascular disease presenting with high-risk clinical features Diana Vassallo, James Ritchie, Darren Green, Nephrology Dialysis Transplantation	2017	41

Page 1